David Goldfarb, MD, Discusses First Over-the-Counter Beverage for Preventing Kidney Stones Moonstone Nutrition , October 21st, 2020
Cognition Therapeutics Elucidates Genetic Mutation that Protects Against Alzheimer’s Disease Press Release , October 19th, 2020
Carmell Therapeutics Announces Appointment of Dr. Israel Nur as Scientific Advisor Press Release , October 7th, 2020
Moonstone Nutrition, Offering the First-Ever OTC Alkali Citrate Drink Formula to Precent Kidney Stones, Announces Education Partnership with National Kidney Foundation Moonstone Nutrition , September 29th, 2020
Moonstone Nutrition Receives Support from the Accelerator Fund to Develop Products to Support Kidney Health Press Release , September 29th, 2020
Cognition Therapeutics Appoints Industry Veteran Jack Khattar to its Board of Directors Press Release , September 9th, 2020
Cognition Therapeutics Announces First Patient Dosed in SEQUEL Study of CT1812 Press Release , August 27th, 2020
Cognition Therapeutics Receives $75.8 Million NIA Grant for 540- Patient Phase 2 Study of CT1812 in Collaboration with the Alzheimer’s Clinical Trials Consortium Press Release , June 8th, 2020